Sunday, March 18, 2012

PPACA Orals at SCOTUS, March 26-28


The complete docket items, including amicus briefs are linked here.

A huge three days of argument, to be sure. I would love to be there. I've read the lengthy contending "briefs." Historic. Is health care properly "interstate commerce" within the jurisdiction of Congress? That is the principal question, IMO. Not that it's the only one relevant to this dispute, a dispute with the most profound of implications.

"COMMERCE,? "MARKETS"?
From my Atlantic Monthly
What Isn’t for Sale?
Market thinking so permeates our lives that we barely notice it anymore. A leading philosopher sums up the hidden costs of a price-tag society.
By MICHAEL J. SANDEL
THERE ARE SOME THINGS money can’t buy—but these days, not many. Almost everything is up for sale. For example:

• A prison-cell upgrade: $90 a night. In Santa Ana, California, and some other cities, nonviolent offenders can pay for a clean, quiet jail cell, without any non-paying prisoners to disturb them.

• Access to the carpool lane while driving solo: $8. Minneapolis, San Diego, Houston, Seattle, and other cities have sought to ease traffic congestion by letting solo drivers pay to drive in carpool lanes, at rates that vary according to traffic.

• The services of an Indian surrogate mother: $8,000. Western couples seeking surrogates increasingly outsource the job to India, and the price is less than one-third the going rate in the United States.

• The right to shoot an endangered black rhino: $250,000. South Africa has begun letting some ranchers sell hunters the right to kill a limited number of rhinos, to give the ranchers an incentive to raise and protect the endangered species.

• Your doctor’s cellphone number: $1,500 and up per year. A growing number of “concierge” doctors offer cellphone access and same-day appointments for patients willing to pay annual fees ranging from $1,500 to $25,000.

• The right to emit a metric ton of carbon dioxide into the atmosphere: $10.50. The European Union runs a carbon-dioxide-emissions market that enables companies to buy and sell the right to pollute.

• The right to immigrate to the United States: $500,000. Foreigners who invest $500,000 and create at least 10 full-time jobs in an area of high unemployment are eligible for a green card that entitles them to permanent residency.

NOT EVERYONE CAN AFFORD to buy these things. But today there are lots of new ways to make money. If you need to earn some extra cash, here are some novel possibilities:

• Sell space on your forehead to display commercial advertising: $10,000. A single mother in Utah who needed money for her son’s education was paid $10,000 by an online casino to install a permanent tattoo of the casino’s Web address on her forehead. Temporary tattoo ads earn less.

• Serve as a human guinea pig in a drug-safety trial for a pharmaceutical company: $7,500. The pay can be higher or lower, depending on the invasiveness of the procedure used to test the drug’s effect and the discomfort involved.

• Fight in Somalia or Afghanistan for a private military contractor: up to $1,000 a day. The pay varies according to qualifications, experience, and nationality.

• Stand in line overnight on Capitol Hill to hold a place for a lobbyist who wants to attend a congressional hearing: $15–$20 an hour. Lobbyists pay line-standing companies, who hire homeless people and others to queue up.

• If you are a second-grader in an underachieving Dallas school, read a book: $2. To encourage reading, schools pay kids for each book they read.

WE LIVE IN A TIME when almost everything can be bought and sold. Over the past three decades, markets—and market values—have come to govern our lives as never before. We did not arrive at this condition through any deliberate choice. It is almost as if it came upon us.

As the Cold War ended, markets and market thinking enjoyed unrivaled prestige, and understandably so. No other mechanism for organizing the production and distribution of goods had proved as successful at generating affluence and prosperity. And yet even as growing numbers of countries around the world embraced market mechanisms in the operation of their economies, something else was happening. Market values were coming to play a greater and greater role in social life. Economics was becoming an imperial domain. Today, the logic of buying and selling no longer applies to material goods alone. It increasingly governs the whole of life.

The years leading up to the financial crisis of 2008 were a heady time of market faith and deregulation—an era of market triumphalism. The era began in the early 1980s, when Ronald Reagan and Margaret Thatcher proclaimed their conviction that markets, not government, held the key to prosperity and freedom. And it continued into the 1990s with the market-friendly liberalism of Bill Clinton and Tony Blair, who moderated but consolidated the faith that markets are the primary means for achieving the public good.

Today, that faith is in question. The financial crisis did more than cast doubt on the ability of markets to allocate risk efficiently. It also prompted a widespread sense that markets have become detached from morals, and that we need to somehow reconnect the two. But it’s not obvious what this would mean, or how we should go about it.

Some say the moral failing at the heart of market triumphalism was greed, which led to irresponsible risk-taking. The solution, according to this view, is to rein in greed, insist on greater integrity and responsibility among bankers and Wall Street executives, and enact sensible regulations to prevent a similar crisis from happening again.

This is, at best, a partial diagnosis. While it is certainly true that greed played a role in the financial crisis, something bigger was and is at stake. The most fateful change that unfolded during the past three decades was not an increase in greed. It was the reach of markets, and of market values, into spheres of life traditionally governed by nonmarket norms. To contend with this condition, we need to do more than inveigh against greed; we need to have a public debate about where markets belong—and where they don’t.

Consider, for example, the proliferation of for-profit schools, hospitals, and prisons, and the outsourcing of war to private military contractors. (In Iraq and Afghanistan, private contractors have actually outnumbered U.S. military troops.) Consider the eclipse of public police forces by private security firms—especially in the U.S. and the U.K., where the number of private guards is almost twice the number of public police officers.

Or consider the pharmaceutical companies’ aggressive marketing of prescription drugs directly to consumers, a practice now prevalent in the U.S. but prohibited in most other countries. (If you’ve ever seen the television commercials on the evening news, you could be forgiven for thinking that the greatest health crisis in the world is not malaria or river blindness or sleeping sickness but an epidemic of erectile dysfunction.)

Consider too the reach of commercial advertising into public schools, from buses to corridors to cafeterias; the sale of “naming rights” to parks and civic spaces; the blurred boundaries, within journalism, between news and advertising, likely to blur further as newspapers and magazines struggle to survive; the marketing of “designer” eggs and sperm for assisted reproduction; the buying and selling, by companies and countries, of the right to pollute; a system of campaign finance in the U.S. that comes close to permitting the buying and selling of elections.

These uses of markets to allocate health, education, public safety, national security, criminal justice, environmental protection, recreation, procreation, and other social goods were for the most part unheard-of 30 years ago. Today, we take them largely for granted.

Why worry that we are moving toward a society in which everything is up for sale?

For two reasons. One is about inequality, the other about corruption. First, consider inequality. In a society where everything is for sale, life is harder for those of modest means. The more money can buy, the more affluence—or the lack of it—matters. If the only advantage of affluence were the ability to afford yachts, sports cars, and fancy vacations, inequalities of income and wealth would matter less than they do today. But as money comes to buy more and more, the distribution of income and wealth looms larger.

The second reason we should hesitate to put everything up for sale is more difficult to describe. It is not about inequality and fairness but about the corrosive tendency of markets. Putting a price on the good things in life can corrupt them. That’s because markets don’t only allocate goods; they express and promote certain attitudes toward the goods being exchanged. Paying kids to read books might get them to read more, but might also teach them to regard reading as a chore rather than a source of intrinsic satisfaction. Hiring foreign mercenaries to fight our wars might spare the lives of our citizens, but might also corrupt the meaning of citizenship.

Economists often assume that markets are inert, that they do not affect the goods being exchanged. But this is untrue. Markets leave their mark. Sometimes, market values crowd out nonmarket values worth caring about.

When we decide that certain goods may be bought and sold, we decide, at least implicitly, that it is appropriate to treat them as commodities, as instruments of profit and use. But not all goods are properly valued in this way. The most obvious example is human beings. Slavery was appalling because it treated human beings as a commodity, to be bought and sold at auction. Such treatment fails to value human beings as persons, worthy of dignity and respect; it sees them as instruments of gain and objects of use.

Something similar can be said of other cherished goods and practices. We don’t allow children to be bought and sold, no matter how difficult the process of adoption can be or how willing impatient prospective parents might be. Even if the prospective buyers would treat the child responsibly, we worry that a market in children would express and promote the wrong way of valuing them. Children are properly regarded not as consumer goods but as beings worthy of love and care. Or consider the rights and obligations of citizenship. If you are called to jury duty, you can’t hire a substitute to take your place. Nor do we allow citizens to sell their votes, even though others might be eager to buy them. Why not? Because we believe that civic duties are not private property but public responsibilities. To outsource them is to demean them, to value them in the wrong way.

These examples illustrate a broader point: some of the good things in life are degraded if turned into commodities. So to decide where the market belongs, and where it should be kept at a distance, we have to decide how to value the goods in question—health, education, family life, nature, art, civic duties, and so on. These are moral and political questions, not merely economic ones. To resolve them, we have to debate, case by case, the moral meaning of these goods, and the proper way of valuing them.

This is a debate we didn’t have during the era of market triumphalism. As a result, without quite realizing it—without ever deciding to do so—we drifted from having a market economy to being a market society.

The difference is this: A market economy is a tool—a valuable and effective tool—for organizing productive activity. A market society is a way of life in which market values seep into every aspect of human endeavor. It’s a place where social relations are made over in the image of the market.

The great missing debate in contemporary politics is about the role and reach of markets. Do we want a market economy, or a market society? What role should markets play in public life and personal relations? How can we decide which goods should be bought and sold, and which should be governed by nonmarket values? Where should money’s writ not run?

Even if you agree that we need to grapple with big questions about the morality of markets, you might doubt that our public discourse is up to the task. It’s a legitimate worry. At a time when political argument consists mainly of shouting matches on cable television, partisan vitriol on talk radio, and ideological food fights on the floor of Congress, it’s hard to imagine a reasoned public debate about such controversial moral questions as the right way to value procreation, children, education, health, the environment, citizenship, and other goods. I believe such a debate is possible, but only if we are willing to broaden the terms of our public discourse and grapple more explicitly with competing notions of the good life.

In hopes of avoiding sectarian strife, we often insist that citizens leave their moral and spiritual convictions behind when they enter the public square. But the reluctance to admit arguments about the good life into politics has had an unanticipated consequence. It has helped prepare the way for market triumphalism, and for the continuing hold of market reasoning.

In its own way, market reasoning also empties public life of moral argument. Part of the appeal of markets is that they don’t pass judgment on the preferences they satisfy. They don’t ask whether some ways of valuing goods are higher, or worthier, than others. If someone is willing to pay for sex, or a kidney, and a consenting adult is willing to sell, the only question the economist asks is “How much?” Markets don’t wag fingers. They don’t discriminate between worthy preferences and unworthy ones. Each party to a deal decides for him- or herself what value to place on the things being exchanged.

This nonjudgmental stance toward values lies at the heart of market reasoning, and explains much of its appeal. But our reluctance to engage in moral and spiritual argument, together with our embrace of markets, has exacted a heavy price: it has drained public discourse of moral and civic energy, and contributed to the technocratic, managerial politics afflicting many societies today.

A debate about the moral limits of markets would enable us to decide, as a society, where markets serve the public good and where they do not belong. Thinking through the appropriate place of markets requires that we reason together, in public, about the right way to value the social goods we prize. It would be folly to expect that a more morally robust public discourse, even at its best, would lead to agreement on every contested question. But it would make for a healthier public life. And it would make us more aware of the price we pay for living in a society where everything is up for sale.
__

Michael J. Sandel, a political philosopher at Harvard, is the author of "What Money Can’t Buy: The Moral Limits of Markets," from which this article is adapted.
Indeed. I'll be buying this book as soon as it hits the "market." I've been giving the topic a lot of thought for quite some time.
___

Zakaria: Health insurance is for everyone

By Fareed Zakaria, TIME.com
Two years ago, Barack Obama signed into law the most comprehensive reform of American health care since Medicare. Most of its provisions haven’t been implemented yet. But the debate about it rages on at every level. Twenty-six states have filed legal challenges to it. And this month the Supreme Court will hear arguments about its constitutionality.
The centerpiece of the case against Obamacare is the requirement that everyone buy some kind of health insurance or face stiff penalties - the so-called individual mandate. It is a way of moving toward universal coverage without a government-run or single-payer system. It might surprise Americans to learn that another advanced industrial country, one with a totally private health care system, made precisely the same choice nearly 20 years ago: Switzerland. The lessons from Switzerland and other countries can’t resolve the constitutional issues, but they suggest the inevitability of some version of Obamacare...

Read the whole thing. Watch the segment on CNN.
___

BACK DOWN IN THE TRENCHES:
MY COLLEAGUE KEVIN AND I YESTERDAY

Monitoring a Saturday training session for chart scanning/EHR conversion process we've been helping a REC client with.




I now feel much better about the clutter in my study.

Sunday, March 11, 2012

Yet another federal public comment period announcement


Workflow Assessment for Health IT Toolkit Evaluation.”

Proposed Project
AHRQ is a lead Federal agency in developing and disseminating evidence and evidence-based tools on how health IT can improve health care quality, safety, efficiency, and effectiveness. Understanding clinical work practices and how they will be affected by practice innovations such as implementing health IT has become a central focus of health IT research. While much of the attention of health IT research and development had been directed at the technical issues of building and deploying health IT systems, there is growing consensus that deployment of health IT has often had disappointing results, and while technical challenges remain, there is a need for greater attention to sociotechnical issues and the problems of modeling workflow.Show citation box


The implementation of health IT in practice is costly in time and effort and less is known about these issues in small- and medium-sized practices where the impact of improved or disrupted workflows may have especially significant consequences because of limited resources. Practices would derive great benefit from effective tools for assessing workflow during many types of health IT implementation, such as creating disease registries, collecting quality measures, using patient portals, or implementing a new electronic health record system. To that end, in 2008, AHRQ funded the development of the Workflow Assessment for Health IT toolkit (Workflow toolkit). Through this toolkit, end users should obtain a better understanding of the impact of health IT on workflow in ambulatory care for each of the following stages of health IT implementation: (1) Determining system requirements, (2) selecting a vendor, (3) preparing for implementation, or (4) using the system post implementation. They should also be able to effectively utilize the publicly available workflow tools and methods before, during, and after health IT implementation while recognizing commonly encountered issues in health IT implementation. In the current project AFIRQ is conducting an evaluation to ensure that the newly developed Workflow toolkit is useful to small- and medium-sized ambulatory care clinic managers, clinicians, and staff...

...The evaluation will be conducted with 18 practices affiliated with one of two Practice-based Research Networks (PBRNs) in Oregon and Wisconsin, and with the Health IT Regional Extension Centers (RECs) in those States. Participants will be recruited who agree to use the Workflow toolkit in their specific health IT project for a minimum of 10 weeks. This will provide an opportunity to observe use of the Workflow toolkit amongst its intended end users, who are best positioned to provide critical feedback to improve the functionality of the Workflow toolkit...

...The estimated total cost to the Federal Government for this project is $793,456 over a 27-month period from September 23, 2011 to December 22, 2013.
__

Request for comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ healthcare research and healthcare information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ's estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology.

Click the workflow graphic above for the link to the HIT Workflow Toolkit.
Written comments should be submitted to:
Doris Lefkowitz, Reports Clearance Officer, AHRQ,
by email at doris.lefkowitz@AHRQ.hhs.gov.


Comment period closes May 8th, 2012
___

Well, needless to say, I found that interesting, given that I do this very kind of work for my REC, e.g.,



Click either snippet above for the link to the full jpeg for each one. The first one comes from a doc who wasted a bunch of my time (and his), only to decide he wanted to ditch his EHR contract and go back into Vendor Selection, right on the heels of our being accorded sandbox access to the product so that we could begin to map specific workflows, particularly those relating to Meaningful Use compliance.

That had to have been several grand of FTE in the commode.

The latter goes to a project now ramping up full-steam as I write this. The OMs get it, but sustaining staff buy-in / "ownership," well, we shall see. We gave them my WKFL spiel (.pps) in their HQ conference room a few weeks back, and have commenced with a paper charts-to-EHR procedure now being fleshed out. Ambitious project, 9 IM docs, 3 sites, all the docs and their MAs have variations in the way they see patients and chart the encounters (BTW, my .xls workflow data capture tool is posted here, at HealthInsight).

___

DIVERSION: THIS JUST IN



Recall my March 2nd post citation of Dr. Novella's video course on "Your Deceptive Mind: a Scientific Guide to Critical Thinking Skills"? (I continue to review it; more to come)

How about The Khan Academy?




Yeah. This drives me back down Into The Weeds':
Abstracting knowledge from the problem-solving activities to which it should relate has damaging effects at many levels. One effect is that formal education becomes focused unduly on personal intellect. Cultivating a narrow range of intellectual skills and temperaments that foster academic success, the culture of education takes interpersonal skills for granted, and devalues manual skills. And it fails to instill the intellectual behaviors and perspectives that foster effective problem-solving (see part V).


In particular, traditional schooling fails to instill high standards of achievement. In most schooling, time is the constant and achievement the variable—precisely the opposite of what true education demands. Students are allotted a fixed amount of time to learn and then permitted to pass exams and courses with a B or C or worse. Inevitably, given the widely varying abilities and inclinations of individual students, not many will have the experience of passing courses at a high level of achievement. This tolerance of lesser achievement is especially harmful when learning is cumulative, that is, when success at one level requires understanding of the material from an earlier level.


Failure to enforce high standards of quality arises from the premise that schooling should instill a fixed core of knowledge, as distinguished from a core of behavior. Teaching high standards of intellectual behavior and teaching a fixed core of knowledge are mutually exclusive when a fixed time is allotted to achieving these goals. One of the three variables (time spent, amount covered and degree of mastery) has to be held constant at a high level, and that constant should be the degree of mastery. Students would differ in the amount they master and the speed with which they do so, but not in the degree of mastery they attain.


Mastery of a core of knowledge should not be the goal of education— especially in an era when knowledge is constantly becoming obsolete and when information technology confers rapid access to more knowledge than anyone can learn and more processing power than anyone’s mind possesses. The goal should be mastering the behaviors involved in applying knowledge to solve problems effectively and efficiently.


Because these principles are ignored, many students pass through 12 or more years of schooling without ever experiencing mastery, while constantly undergoing invidious comparisons to the best students. This system is harmful even for those best students, for they may acquire elitist attitudes, superficial understanding and misplaced confidence that their academic proficiency will translate into effective problem solving. For less successful students, schooling is too often experienced as a caste system rather than a vehicle for personal development. Many students emerge from their schooling with their natural abilities undeveloped and their natural optimism defeated. To fight back, some adopt an attitude of disdain towards education and intellect. These reactions to formal education are like the reaction of dying canaries in a coal mine—highly sensitive indicators of toxic conditions. In varying degrees, many students are left without the capacities and confidence that only achievement can confer and without the expanded horizons that only education can provide.
[Medicine in Denial, pp 229-230]

UPDATE:
INTERESTING SHOOT-OUT AT THE ONC / HIT PRESS CORRAL

 Dr. Mostashari is not amused:

Apparently, doctors who order a lot of imaging tests are more likely to have electronic systems that let them view those images in their offices.

That is the finding of an article appearing in the March 2012 issue of Health Affairs by McCormick and colleagues. This is not a particularly surprising observation. What is surprising is that the authors go far beyond the scope of their research to conclude that “the federal government’s ongoing, multibillion-dollar effort to promote the adoption of health information technology may not yield anticipated cost savings from reductions in duplicative diagnostic testing. Indeed, it is possible that computerization will drive costs in this area up, not down.”...
To which the study authors publicly replied on The Health Care Blog:
Our recent Health Affairs article linking increased test ordering to electronic access to results has elicited heated responses, including a blog post by Farzad Mostashari, National Coordinator for Health IT. Some of the assertions in his blog post are mistaken. Some take us to task for claims we never made, or for studying only some of the myriad issues relevant to medical computing. And many reflect wishful thinking regarding health IT; an acceptance of deeply flawed evidence of its benefit, and skepticism about solid data that leads to unwelcome conclusions...
Place your bets, pass the popcorn...

McCormick, Bor, Woolhandler, andHillemstein conclude in rebuttal of Farzad:
Dr. Mostashari is also correct in reiterating that randomized trials are the best way to assess health IT. In fact, no randomized trial has ever been published that examines patients’ outcomes or costs associated with off-the-shelf health IT systems that dominate the U.S. market. No drug or new medical device could pass FDA review based on such thin evidence as we have on health IT. Yet his agency is disbursing $19 billion in federal funds to stimulate the adoption of this inadequately evaluated technology. Dr. Mostashari is perhaps the only person in our nation who commands the resources needed to mount a well done randomized controlled trial to fairly assess the impact of health IT, and the comparative efficacy of the various EHR options.


Finally, Dr. Mostashari’s unbridled faith in technology is mirrored by his belief that ACOs are the next panacea for health costs and quality. That health policy flavor-of-the-month also remains wholly unproven.
OK, putting aside for the moment the partisan cheap-shot questions begged by their final paragraph:
  • ...no randomized trial has ever been published that examines patients’ outcomes or costs associated with off-the-shelf health IT systems that dominate the U.S. market.
Precisely how would you design and execute such a study, particularly at a time when HIT markets are ramping up at warp speed? Which "dominant" off-the-shelf systems would get included (based on what cut-off %'s of current ambulatory and inpatient market shares)?

As I write this (3/13) there are a total of 1,817 "Certified" EHR ambulatory and inpatient systems and modules (including 913 "complete" systems). Who gets "studied," who gets left out? Would these be "Dummy Clinic" mock trials, or operational CER?

What would be the "control" (i.e., stratified representative samples of equivalent paper practices and institutions)?

  • No drug or new medical device could pass FDA review based on such thin evidence as we have on health IT.
Are you asserting that we simply don't know? (Rumsfeld's "unknown unknowns"?) Or that we have "evidence," (like your own reported "null" findings) but it is either equivocal or too sparse to lean on comfortably? Moreover, there are plenty of HIT press reports indicating that the FDA wants no part of this potentially radioactive oversight. They have a full plate already. Apropos, see my November 2010 blog post "First, do no Hold Harmless'."
  • Dr. Mostashari is perhaps the only person in our nation who commands the resources needed to mount a well done randomized controlled trial to fairly assess the impact of health IT, and the comparative efficacy of the various EHR options.
Methinks you overstate his brief (e.g., see ARRA Title XIII, Subtitle A, Section 3001 et seq). ONC is a very small shop, as federal Beltway entities go. While you could construe Sec. 3001(b)(2)-(10) as requiring HIT "RCTs," it would seem a stretch to me.
 
But, more on the ONC mandate shortly.

Not that I disagree that we need "comparative effectiveness research" broadly -- though, it will be difficult to parse the relative contributory effects of physical workflow, HIT "information" flow, and clinical decision-making (again, see "Medicine in Denial").

  • Finally, Dr. Mostashari’s unbridled faith in technology is mirrored by his belief that ACOs are the next panacea for health costs and quality. That health policy flavor-of-the-month also remains wholly unproven.
I find this to be an unhelpful ad hominem low blow. Congress, not Farzard, wrote the authorizing ACO subtitle in PPACA. Whether it turns out to be successful is yet to be determined. I've written about ACOs before. So, yeah, it's as yet "wholly unproven." Help me out here. Are we doing science, or Creation Science? Do the critics have any concrete, plausible counter-proposals? Or, is the paper chart FFS paradigm the terminus of health care progress?

Asked and Answered. You want to help improve HIT effectiveness? 


Change.The.Payment.Paradigm.
 

Not that we need not work simultaneously on HIT "usability." My record as a certifiable Crank on that issue is by now well-established.

I'm not the only one who took issue with the study's final paragraph. From the Health Affairs blog itself:
jgogek Says:
March 12th, 2012 at 6:48 pm
While in general I’m glad to see researchers vigorously defend their research, I’m left wondering about the gratuitous slam against ACOs in the last paragraph of the above blog post. Calling ACOs “flavor-of-the-month” and “wholly unproven” is simply pejorative and has nothing to do with the substance of the research in dispute. It tarnishes the authors’ objectivity. In fact, it makes them seem kind of chippy.
Indeed. One more commenter weighed in, at ModernHealthcare.com
Al Puerini
ModernHealthcare.com, Mar 15. 2012 7:07pm
I completely agree with Dr Mostashari. The only "deeply flawed evidence" is what they used to come to their study conclusions. To say that EHR vendor's "products have undergone mostly modest tweaks" since 2008 is incredibly naive and shortsighted. EHR's have changed dramatically in the last 4 years and many still have much to do to achieve meaningful use. If one cannot see the positve and deep changes in EHR's over the past 4 years as a result of the development of the PCMH and achieving Meaningful Use, then they are not paying attention to what is happening in the real world. And more to come! When hospitals, PCP's and specialists start communicating with each other through their EHR's, the savings will be huge. And that movement is well on its way. Keep up the good fight, Farzad. Your leadership is changing health IT in a strongly positive way.
Al Puerini, MD
President, RI Primary Care Physician Corporation 
___

DAVID DRANOVE WEIGHS IN


From Code Red:
...The other item that caught my attention was a study in Health Affairs showing that physicians who have electronic access to test results (via electronic medical records) order more tests than physicians who do not. The New York Times ran both an article and an editorial about the study. The finding is based on a single year of cross-section data. All first year graduate students in the social sciences should immediately recognize that this study suffers from endogeneity bias. The “treatment” (i.e., access to test results through EMR) is potentially correlated with unobservable physician characteristics that end up in the error term of the regression. As a result, causality is in doubt.

Let me offer several candidate explanations for the findings. First, it could be that access to test results encourages doctors to find ways to increase testing (the negative connotation offered by the author and the New York Times.) Second, it could be that some doctors have a technological bent. They tend to order lots of tests and they are first to have access to EMR. Thus, there is a correlation between testing and EMR but the latter does not cause the former. Third, some doctors may order an above average number of tests. Forced by managed care and Medicare to reduce costs, they seek a way to get testing under control. They install EMR which gives them access to prior test results. This allows them to reduce testing , though not by enough to put them below the average. Again, there is a correlation between testing and EMR, but in this case EMR leads to less testing. There may be other possibilities. My point is not that I know what causes what. My point is that no one knows what causes what.

Fortunately, there are research methods that can help sort out causality. I happen to be working on a similar study using these methods. In an upcoming blog, I will share some preliminary findings. My coauthors and I get a similar correlation, but reveal an interesting pattern of causality that may provide hope to those who believe that EMR can rescue the healthcare system.

AND, THE HITS JUST KEEP ON COMIN'

 

ERRATUM

Apropos of "imaging," I ran across this recent paper published by ACS. I snipped out this graphic and annotated it (click to enlarge)

 
To reduce future projected cancers from diagnostic procedures, we advocate the widespread use of evidence- based appropriateness criteria for decisions about imaging procedures; oversight of equipment to deliver reliably the minimum radiation required to attain clinical objectives; development of electronic lifetime records of imaging procedures for patients and their physicians; and commitment by medical training programs, professional societies, and radiation protection organizations to educate all stakeholders in reducing radiation from diagnostic procedures. CA Cancer J Clin 2012;62:75-100. Published 2012 American Cancer Society.
A better than 550% increase in per capita ionizing dose exposure relative to a constant natural sources denominator (2.4 mSv). Interesting. I started my white collar career in 1986 doing environmental dose/exposure related stuff in a forensic-level Rad/Mixed Waste lab in Oak Ridge, under the esteemed John A. Auxier, PhD and his stable of top-tier Health Physicists, so I found these data intriguing.
___


NEW COMMONWEALTH FUND REPORT


Executive Summary
People in the United States, regardless of where they live, deserve the same opportunities to lead long, healthy, and productive lives. Achieving that goal means that all communities should receive the very best from their local health care systems. Yet this new Scorecard on Local Health System Performance finds that where one lives has a major impact on the ability to access health care and the quality of care received. Comparing the 306 local health care areas, known as hospital referral regions, in the United States, the report finds wide variations on key indicators of health system performance. Access to care, quality of care, costs, and health outcomes all vary significantly from one local community to another, both within larger states and across states. There is often a two- to threefold variation on key indicators between leading and lagging communities. The 30 top-performing local areas include communities in the Northeast, Midwest, and a few West Coast communities—with these leading areas often doing well on multiple indicators and dimensions of care. Yet while pockets of excellence exist, there are ample opportunities for health system improvement in all communities, even among the leaders...
98 pages of incisive stuff. Below, this is pretty interesting.


As is this:


Can you say "Gawande"? You could spend a month just interpreting this stuff. Couple of words and phrases come straight to mind: "Disparities," "Health Impact Assessments."
___
More to come...

Wednesday, March 7, 2012

MU Stage 2 and 2014 CEHRT Public Comment Period thru May 7th, 2012

Click either screen snip below (they open in new windows).
You have a voice. Use it.

___

Logo/Branding Launch:
HealtHIE Nevada Town Hall Meeting



I've known about this for a while, but had to keep it under wraps pending Board approval. Kudos to the designer, Alex
. A home run, IMO. We unveiled it today at an offsite stakeholder "Town Hall Meeting."

Below, our Marketing and Communications Lead Kym Roundtree gets things going

Next up, our Executive Director Deborah Huber.

Above, Imagine Communications Creative Director Alex Raffi. Dude, when do I get my t-shirt? XL, full frontal logo.

Below, my friend Erick Maddox, our HealthInsight Nevada REC Manager, takes the crowd through the impending Stage 2 Meaningful Use HIE implications.
In three words
: Ongoing Interoperable Exchange.

Above our HealtHIE Nevada Manager Rachel Papka takes us through our next steps path.

Below, I was doodling around in Photoshop last night at home while watching and listening to the GOP Stupor Tuesday Primary returns. I have maybe 15-20 minutes in this pastiche. Click to enlarge.



Interesting that the iPad3 was unveiled today.

Ahhh...The Power of Photoshop Compels Me,
The Power of Photoshop Compels Me, The Power of Photoshop Compels Me, The Power of Photoshop Compels Me...

___

GOTTA LOVE THIS

It all seemed so easy

In 2010 an article was published in the New England Journal of Medicine, Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus. Patients were screened for Staphylcoccus aureus ( including MRSA, methicillin resistant Staphylococcus aureus) and those that were positive underwent a 5 day perioperative decontamination procedure with chlorhexidine baths and an antibiotic, mupirocin, in the nose. The results were impressive. Before the intervention the infection rates were 7.7 % and after the intervention it was 3.4 %. That is an impressive drop in surgical infections.

One of the orthopedic groups approached us (us being the hospital administration, pharmacy, nursing and infection control, of which I am Chair) to implement the protocol in their patients, citing a similar study on an orthopedic population. Great. It should be an easy enough intervention. I should have known better, of course, long experience has continually demonstrated that what appears to be simple never is...
Great article.


Friday, March 2, 2012

Two years on...


Two years ago today, Erick, Catelyn Eileen, and this ol' Dawg came on board to commence a month's worth of intensive study (mostly MU Stage 1 IFR) and internal training requisite for the ensuing full-bore, full-contact deployment of our Nevada-Utah REC effort. On the following May 10th I launched this blog.
It was not universally loved at HQ at the outset.

Well, notwithstanding, I was not to be deterred. Nor shall I stop now. There's just too much good stuff going on. Too much to continue to learn. Stuff with stakes of real consequence for the benefit of society.

___

UPDATES

I just bought and downloaded this series.


Click the thumbnail graphic above for the link. Looks great thus far. 60 bucks for 12 hours of A/V lecture material from a respected subject matter heavy hitter? Nice. I'm gonna watch it all before saying much more, and I've got other balls in the air.
___

BACK TO REC-RELATED STUFF


A HIMSS12 press contact from Price Waterhouse Coopers sent me this. Some interesting stuff
:
Outcomes-based reimbursement is the future of the heath industry. To improve patient outcomes, proactively identify chronic and high-risk patients in this new environment, and effectively manage their financial performance, healthcare organizations must be able to provide analytics at the point of service and rely on historical and longitudinal data to manage patient populations.

One constant in all of the new care and reimbursement models is data. With the digitization of healthcare, new opportunities are rising from a marked increase in the channels, volume, and complexity of information available. Organizations will compete on how effectively and affordably they manage patient care and identify patients who need preventive care. Healthcare organizations need strategies for mining data, conducting and integrating evidence-based research, translating findings into practice, and driving the behavior changes required for patient compliance.

The United States is in the midst of its largest health information technology (IT) investment and transformation. So far, the federal government has paid $2.5 billion in incentives to 800 hospitals and 33,000 physicians for using electronic health records (EHRs). Thousands more are in the pipeline to receive the bonuses, which could total $28 billion by 2015. Paper records are fading away. IDC Health Insights predicts that the majority of U.S. providers will use an EHR by the end of 2012.

Now, they’re moving quickly to capitalize on all of this data. It is no longer good enough to know what happened and why it happened six months ago; organizations need to know what is happening in real time, what is likely to happen next, and what should be done now. This new focus on informatics applies to the provider, payer, and pharmaceutical sectors, each of which has unique expectations, needs, and challenges.

Last but not least are the patients. In this changing landscape of new technologies, regulatory requirements, and healthcare enterprise strategies, all health sectors view patient engagement as a way to drive profit, either through cost reduction or revenue increases. Now, they must find ways to engage patients in their clinical informatics efforts...
They are frank to note some persistent barriers:
Technology

Data integration and lack of standards are the biggest challenges:
Not long ago, health professionals’ principal complaint was the lack of funds to invest in health IT. The world has changed. The HIMSS Nursing Informatics Workforce Survey historically showed financial resources as the top barrier to their work. In 2011, it shifted to lack of integration/ interoperability. Indeed, all health sector professionals HRI surveyed cited data integration and interoperability struggles. Among providers and health insurers, 71% of respondents said integrating data from multiple sources was the top technical goal of their organization over the next two years. Next in the line of technical goals was data standardization (rather than documentation standardization), with 56% of the respondents indicating this as a goal and 86% classifying it as challenging to accomplish.
Two of the greatest technology challenges that emerged in the research were lack of standards and lack of confidence in vendors. Lack of standards: As the Office of the National Coordinator’s Health IT Standards Committee works on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information, lack of industry standards was a common theme during interviews across the sectors, even from organizations that are leaders in informatics. Nearly 84% of survey respondents indicated standardizing data would be either very challenging or challenging to accomplish in meeting their technical goals over the next two years. “If you look at the ‘meaningful use’ standards, there’s not a single data quality standard among them,” said Texas State’s Fenton. “There are organizations that have ‘pancake people’ entered in their systems — records of patients with a height of 5 inches and weight of 300 pounds, for example. That’s a problem if the medicine you’re giving is based on body mass index. There needs to be consideration for dynamic versus static data. Date of birth and ethnicity shouldn’t have to be entered more than once,” she said. Another challenge is the conflict between providing rich data and creating an easily adoptable process. For example, free form narratives in physicians’ notes contain critical details, but they require more sophisticated data mining techniques, such as natural language processing or other “listen and interpret” technology. Nearly all interviewees remarked about the importance of this non-discrete data, but they struggle to find a balance between creating too few and too many forced data fields within their clinical systems for making data discrete, and therefore, easier to mine...
That last paragraph brings to mind Praxis EMR. I have but one solo doc EP on that platform, with whom I've honestly not had much interaction (I stay pretty much in "Squeaky-Wheel World" with respect to my EP caseload), so I really can't say whether the Praxis "Template-Free" approach might get us a two'fer: "nuanced" impressionistic free-text notes and structured data for statistical mining.

Dubious, in a word.

With respect to "pancake people," I've long been a crank regarding "data quality" -- the GIGO thing that won't be addressed by HIE "authentication" protocols and Stage 2 "interoperability" requirements.

“If you look at the ‘meaningful use’ standards, there’s not a single data quality standard among them.” Yeah, ouch. That has to change. My wife and I both cut our professional teeth in the contractual and regulatory "DQO" world -- Data Quality Objectives, often hewing to forensic QA standards. (we frequently worked on stuff for radiation dose/exposure litigation).

This is as close as you'll get within the proposed 2014 CEHRT standard (PDF):
The International Organization for Standardization (ISO) defines usability as “[t]he extent to which a product can be used by specified users to achieve specified goals with effectiveness, efficiency, and satisfaction in a specified context of use.” Many industry stakeholders have acknowledged that a gap exists between optimal usability and the usability offered by some current EHR technologies. However, to date, little consensus has been reached on what might help close this gap and what role, if any, the Federal government should play related to the usability of EHR technology. In June 2011, the HITPC issued a report to ONC that explored the challenges associated with EHR technology usability and user-centered design (UCD). In its report, the HITPC identified certain “desired outcomes of improved usability” including improved safety and reduced cost, clinician frustration, training time, and cognitive load for clinical and non-clinical users alike. In November 2011, the Institute of Medicine (IOM) released a report titled “Health IT and Patient Safety: Building Safe Systems for Better Care,” in which the usability of EHR technology and quality management was often referenced. The IOM noted that “[w]hile many vendors already have some types of quality management principles and processes in place, not all vendors do and to what standard they are held is unknown.” Moreover, given this concern, the IOM recommended that “[t]he Secretary of HHS should specify the quality and risk management process requirements that health IT vendors must adopt, with a particular focus on human factors, safety culture, and usability.”... [pp 38-39]
OK, but, absent data quality standards, making it easier to input garbage data (nominal "usability" willy-nilly) will have its consequences as well.

The upshot of which should be obvious.
___
OK, AS IF WE DIDN'T ENOUGH TO FRET ABOUT


I downloaded this today into the Cognitive Crack Pipe that is my Kindle. Apropos of all the sexy "Personalized Medicine" infatuation of late:
9. We Confuse DNA with Disease How Genetic Testing Will Give You Almost Anything
I really like the science of genetics. In high school, I enjoyed calculating the probabilities of various genotypes using the simple genetics Gregor Mendel discovered cultivating pea plants. In college, I was fascinated to learn how the selective pressures exerted by one very common infectious disease (malaria) actually favored the persistence of particular genetic diseases in human populations (sickle cell disease, glucose-6-phosphate dehydrogenase deficiency). And in medical school, I was intrigued by the mechanics of DNA: how the double helix is replicated, how it gets transcribed into RNA to make proteins, how it gets recombined so we can pass on some of our mothers and some of our fathers to our children, and how it can get usurped by other life forms (viruses) so that our cells work for them. Genetics is a wonderful mix of mathematics, evolutionary biology, and biochemistry. It’s good stuff. But I am much less enamored of the idea of testing healthy people’s genes. Some think that genetic testing will provide a road map to optimal health. Genetic testing is already useful in helping us tailor therapy to individual cancers and is likely to become more useful in predicting how well patients will respond to various drugs. And gene therapy—treatment for a specific disease that involves altering DNA itself—could, in certain settings, prove to be a genuine medical cure. But genetic testing could just as easily be a road map to widespread ill health.
Already, numerous commercial enterprises exist that will take your DNA (and your money) and tell you about your future. One such company, 23andMe, promises to “unlock the secrets of your own DNA,” while Navigenics wants you to be tested “do everything you can to stay healthy.” And deCODEme hopes that genetic testing will “prompt people to do the right thing.” This commercialization of genetic testing appears to be selling health, but from my standpoint at least, it’s selling overdiagnosis. Genetic testing of healthy people is the most extreme manifestation of early diagnosis. Here the diagnosis being sought is not a disease but rather the underlying genetic predisposition for a disease. In short, genetic testing is looking for genetic risk factors. Because everybody is at risk for something, it’s a strategy that will make literally all of us sick. We already have genetic tests to screen for the predispositions to a lot of diseases—more than I could possibly cover here. And because we are in the midst of an explosion of genetic research, we will undoubtedly have even more tests by the time you are reading this. But the fundamental questions about genetic testing will not change. They are the same ones that should be asked about any early diagnosis effort: How many people will needlessly be told that they are somehow abnormal? What will we do to them?...

Genetics is not destiny
The information contained in genes is often described as the blueprint for the human body, although some scientists feel that the more appropriate analogy is to a recipe, which turns out a little different each time. There is a gene with a set of instructions responsible for eye color, another with instructions for how to make insulin, and another with instructions that may or may not enable you to roll your tongue. And you have about twenty-five thousand others. Genes are composed of only four building blocks, whose names are abbreviated with the letters A, C, G, and T. The code is formed by stringing these building blocks together; the average gene has three thousand building blocks (the range is from 252 to 2.4 million). The vast majority—over 99 percent—of this genetic information is identical in all of us. This makes sense, since we all have so much in common: we each have two eyes and one heart (with the same four chambers), we each walk erect, and so on. But the small amount of genetic information that does differ from person to person really matters. It’s a big part of what makes people different from one another. In the simplest case, genetics would be completely deterministic. Genes alone would be solely responsible for individual characteristics. But genetic variation is not the whole story. Even identical twins, who have exactly the same DNA, or genotype, are not exactly the same. Environmental factors, particularly in early life, also matter. Things like nutrition and harmful exposures to toxins or radiation affect human characteristics, even before birth, as does physical and intellectual activity in childhood. There is a broad scientific consensus that virtually all variation is the result of the interaction between genes and environmental factors. And then there is luck, or the random play of chance. The same genotypes in the same environment may still yield quite different people. This leads to a key distinction that is relevant to genetic testing: the distinction genotype and phenotype. The complete set of genetic instructions contained in your DNA is your genotype. The human that others can observe—your physical, biochemical, and behavioral characteristics—is your phenotype. You don’t experience your genotype; you experience your phenotype. And it is the combination of your genotype, your environment, and luck that determines your phenotype. Genetic testing attempts to predict your phenotype based solely on your genotype. While there’s really no reason to have a genetic test to predict an aspect of your phenotype you already know about—you wouldn’t, for example, do a genetic test to see if you had blue eyes—some genetic-testing companies are in fact promoting tests just like this. They claim they can test your genes to see whether you have trouble tolerating milk products, or whether you have problems with ear wax, or even whether you like Brussels sprouts...

10: Get the Facts

A lot of messages about health screening are simply variations on the same theme—in one form or another, they all push the idea that the best way to stay healthy is to look hard for things that might be wrong. Sometimes the messages reflect the best of intentions: disease advocacy groups and some doctors advise people to be screened because they believe it is right thing to do. Others times they reflect more self-serving motives: health-care companies, hospitals, and some doctors advise people to be screened because they are in the business of selling the service. But regardless of the underlying motivation, what you really need to know is whether these messages are supported by good hard facts.

I should start by telling you the unfortunate reality: all too often, there won’t be any good hard facts to find. There is a reason for this. Most healthy people will not soon (or ever) develop the particular disease we are trying to diagnose early. So getting reliable information about the value of early detection for the few who will get the disease requires studying a lot of healthy people for a long time. And a big, long study is a very expensive study. The numbers are impressive: a typical randomized trial of mammography, for example, enrolled around fifty thousand women, followed them over a decade, and cost tens of millions of dollars. Not surprisingly, there are not a lot of these studies, although there should be. The millions we would pay to study the value of early detection pales in light of the billions we spend putting it into practice without knowing if it helps.

But since there aren’t a lot of good hard facts out there, it is important to recognize when you are being led to believe that people know more than they do. Many messages about early detection—advertisements, public service announcements, health Web sites, and even news reports—are plainly misleading. They typically exaggerate the risks you face as a way to scare you into taking action.


Yeah, geez, we're Overdiagnosed, and then subsequently typically "Overdo$ed." And, HIT/HIE unconstrained by DQO stds, along with e-Rx are gonna make it easier than ever, Bayesian considerations and lack of software QA rigor notwithstanding.

SUNDAY UPDATE

Nice comment on The Health Care Blog:
Blackcoat says: March 4, 2012 at 11:30 am

To take a page from the field of finance, the problem here is about Black Swans and Complexity. Understanding risk, data, probability, statistics, and choice – whether in personal health or investing – is challenging on a good day. It’s hard for people to take in a constant shifting mass of information and to weigh risks and benefits.

When it comes to money or health, there’s so much emotion and important variables at stake, it’s even harder. Most people don’t want lots of information or deep statistical analysis. They just want to be told what to do, by the experts that they trust...
'eh?
___

OPINION


MARCH 6th QUICK UPDATE

View more presentations from SuccessEHS
Interesting. 3rd slide tabulates the top HIE vendors. More thoughts about this shortly...
___

March 6th, GOP Stupor Tuesday errata

"HIE"? DOA?

Be There From Anywhere: The AirStrip Story
"AirStrip Technologies built its revolutionary AppPoint™ software development platform with a vision of securely sending critical patient information directly from hospital monitoring systems, bedside devices, and electronic health records [emphasis mine] to a clinician's mobile device. AppPoint was also designed to solve core challenges in mobile software development, such as developing native applications that provide the requirements of a rich user experience while at the same time being able to scale and adapt to an ever changing world of mobile operating systems and devices. FDA cleared and HIPAA compliant, AirStrip applications are powered over wired and wireless networks, delivering virtual real-time waveform and other relevant clinical data - anytime, anywhere..."
OK, I saw this news item today that HCA Sunrise (Vegas) is now deploying some of this technology. Interesting.

HCA West (Sunrise Health System) has a seat on our HealtHIE Nevada Board. Hmmm...
___

More to come...